Atilano, Rivalle Eren I.

HRN: 16-01-58  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/16/2022
CEFUROXIME 1.5GM (VIAL)
09/16/2022
09/23/2022
IV
260 Mg
Q8H
UTI
Waiting Final Action 
09/17/2022
CEFTRIAXONE 1G (VIAL)
09/17/2022
09/24/2022
IV
1200mg
OD
Typhoid Fever
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: